Both in Pharmaceuticals
Mineralys Therapeutics vs Damora Therapeutics
Over the past year MLYS returned −44.9% and DMRA returned −23.1%; their daily moves had a correlation of 0.37.
MLYS −44.9% DMRA −23.1%Growth of $1, one year, split-adjusted
| Metric | MLYS | DMRA |
|---|---|---|
| Price | $15.55 | $21.60 |
| Market cap | $1.37B | $1.33B |
| Today | −14.47% | +0.51% |
| 1 month | −34.2% | +4.6% |
| 6 months | −47.6% | — |
| Year to date | −57.2% | — |
| 1 year | −62.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $563.8M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | — |
| Short % of float | 11.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).